Skip to main content

Table 5 Comparisons of ELBW infants with PDA closed by COI treatment vs. those with PDA who failed medical treatment and underwent surgical ligation

From: Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants

 

COI Only (n = 48)

COI & Ligation (n = 32)

P

BW, gm

772 (16)

726 (24)

ns

GA, wks

25.4 (0.2)

24.9 (0.2)

ns

Male Gender (%)

26 (54%)

12 (38%)

ns

CRIB II score

12.1 (0.3)

12.9 (0.4)

ns

OI

3.9 (0.3)

4.5 (0.5)

ns

COI courses

1.6 (0.1)

2.3 (0.1)

< 0.001

Age 1st Dose, days

5.6 (0.6)

7.5 (2.3)

ns

CLD

21 (43.8%)

21 (65.6%)

ns

NEC

6 (12.5%)

2 (6.3%)

ns

IVH III-IV

4 (8.3%)

2 (6.3%)

ns

ROP

29 (60.4%)

22 (68.8%)

ns

Age at extubation, days

27 (5)

33 (5)

ns

Age at full feeds, days

33 (2)

34 (2)

ns

Age at discharge, days

102 (4)

110 (14)

ns